E

Evaxion Biotech A/S American Depositary Share

EVAX

2.93000
USD
-0.05
(-1.68%)
مغلق
حجم التداول
220
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
14,441,982
أصول ذات صلة
L
LUNA
0.02000
(0.67%)
3.01000 USD
NEOUSD
-0.093
(-0.87%)
10.505 USD
N
NEO
-0.270
(-1.52%)
17.500 USD
S
SOL
-0.07500
(-4.50%)
1.59000 USD
الأخبار المقالات

العنوان: Evaxion Biotech A/S American Depositary Share

القطاع: Healthcare
الصناعة: Biotechnology
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.